Multicenter randomized trial conducted among @ critically ill immunocompromised patients , of whom @ ( @ % ) were receiving treatment for hematologic malignancies or solid tumors , at @ intensive care units ( ICUs ) in France and Belgium between August @ , @ , and January @ , @ .